The Health Impact Fund: incentives for improving access to medicines

被引：50

作者：

Banerjee, Amitava ^{[1
]}

Hollis, Aidan ^{[3
]}

Pogge, Thomas ^{[2
]}

机构：

[1] Univ Oxford, Stroke Prevent Res Unit, Oxford OX3 9DU, England

[2] Yale Univ, Dept Philosophy, New Haven, CT USA

[3] Univ Calgary, Dept Econ, Calgary, AB T2N 1N4, Canada

来源：

LANCET | 2010年 / 375卷 / 9709期

关键词：

PATENTS;

D O I：

10.1016/S0140-6736(09)61296-4

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：166 / 169

页数：4

共 21 条

[1]

[Anonymous], 2009, LANCET, V373, P693, DOI 10.1016/S0140-6736(09)60410-4

[2]

[Anonymous], 4703 WPS WORLD BANK

[3]

[Anonymous], TRAD REL ASP INT PRO

[4]

[Anonymous], WORLD DRUG SIT

[5]

How do patents and economic policies affect access to essential medicines in developing countries? [J].

Attaran, A .

HEALTH AFFAIRS, 2004, 23 (03) :155-166

[6]

Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa? [J].

Attaran, A ;

Gillespie-White, L .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (15) :1886-1892

[7]

BACIU A, 2007, FUTURE DRUG SAFETY P

[8]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[9]

An Uncertain Future for Cardiovascular Drug Development? [J].

Garber, Alan M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (12) :1169-1171

[10]

In search of a corrected prescription drug elasticity estimate: A meta-regression approach [J].

Gemmill, Marin C. ;

Costa-Font, Joan ;

McGuire, Alistair .

HEALTH ECONOMICS, 2007, 16 (06) :627-643

← 1 2 3 →